These results strongly indicate that reduced TRIM21 expression is probably a cause, not a consequence, of obesity-associated metabolic disorder, which was further supported by the hepatic TRIM21 knockdown experiment in mice, which promoted liver steatosis and insulin resistance. The gene discussed is TRIM21; the disease is metabolic disease.